<DOC>
	<DOCNO>NCT01388439</DOCNO>
	<brief_summary>Oseltamivir dose infant &lt; 3 month age base single pharmacokinetic study 20 infant single center . This dataset limit lack robustness , 1 sample collect participant . The investigator obtain two blood sample infant receive oseltamivir obtain informed consent infant 's parent . The investigator propose analyze blood sample determine amount oseltamivir infant 's blood . Measurement value increase understanding absorption elimination oseltamivir preterm term infant , improve ability provide correct dos high risk population .</brief_summary>
	<brief_title>Pharmacokinetics Oseltamivir Newborns Infants</brief_title>
	<detailed_description />
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>All neonates infant NICU St. Louis Children 's Hospital receive oseltamivir treatment exposure influenza virus type A consider eligible study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>oseltamivir</keyword>
	<keyword>influenza</keyword>
	<keyword>neonate</keyword>
	<keyword>premature</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>